Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen retirement and Savings Plan for Amgen Manufacturing Limited (Puerto Rico Form 11-K) — Net Assets ($M) ($M)
Form 11-K Retirement and Savings Plan for Amgen Manufacturing Limited (Puerto Rico)
Latest, FY2025
931
Period ended Dec 31, 2025
Change on a year earlier
+19.3%
780 in FY2024
History
9 years
Since FY2017
Sources
8
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up retirement and savings plan for amgen manufacturing limited (puerto rico form 11-k) — net assets ($m)
- Puerto Rico Plan — Investments at Fair Value ($M)911 · FY2025
- Puerto Rico Plan — Amgen Inc. Common Stock Held in Plan ($M)101 · FY2025
- Puerto Rico Plan — Notes Receivable from Participants ($M)19.4 · FY2025
- Puerto Rico Plan — Employer Contributions ($M)22.6 · FY2025
- Puerto Rico Plan — Participant Contributions ($M)20.0 · FY2025
- Puerto Rico Plan — Participant Rollover Contributions ($M)1.11 · FY2025
- Puerto Rico Plan — Dividend and Interest Income ($M)6.49 · FY2025
- Puerto Rico Plan — Net Realized and Unrealized Gains (Losses) on Investments ($M)124 · FY2025
- Puerto Rico Plan — Benefits Paid to Participants ($M)25.2 · FY2025
- Puerto Rico Plan — Administrative Expenses ($M)0.45 · FY2025
Cite this data
StockData. (2026). Amgen Retirement and Savings Plan for Amgen Manufacturing Limited (Puerto Rico Form 11-K) — Net Assets ($M) ($M), annual FY2017–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/plan_pr_net_assets
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.